Curis
CRIS
#10279
Rank
C$28.31 M
Marketcap
C$0.71
Share price
-6.22%
Change (1 day)
-57.07%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -C$45.86 Million

According to Curis's latest financial reports the company's current earnings are C$11.65 Million. In 2024 the company made an earning of -C$59.15 Million, an increase over its 2023 earnings that were of -C$62.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$45.86 Million-22.47%
2024 -C$59.15 Million-5.77%
2023 -C$62.77 Million-13.1%
2022 -C$72.23 Million27.52%
2021 -C$56.64 Million65.09%
2020 -C$34.31 Million-9.1%
2019 -C$37.75 Million-4.73%
2018 -C$39.62 Million-41.95%
2017 -C$68.24 Million-14.37%
2016 -C$79.69 Million3.55%
2015 -C$76.96 Million271.52%
2014 -C$20.72 Million76.64%
2013 -C$11.73 Million
2011 -C$9.96 Million27.76%
2010 -C$7.8 Million-43.87%
2009 -C$13.89 Million-23.44%
2008 -C$18.15 Million56.66%
2007 -C$11.58 Million-16.71%
2006 -C$13.91 Million-36.92%
2005 -C$22.04 Million156.25%
2004 -C$8.61 Million-37.24%
2003 -C$13.71 Million-93.34%
2002 -C$0.21 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.09 B-31,404.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.89 B-28,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$85.57 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.30 B-2,990.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.4 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$34.24 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA